Alzeimer’s Care
Introducing LEQEMBI: A New Horizon in Alzheimer’s Treatment
Discover LEQEMBI, the latest advancement in Alzheimer’s disease management, offering hope and improved quality of life for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease.
Administration Information
LEQEMBI is administered via infusion, tailored to each patient’s specific needs and medical profile, ensuring optimal care and effectiveness.
Types of Medical Conditions Associated With LEQEMBI
LEQEMBI (lecanemab-irmb) is specifically designed to treat certain types of Alzheimer’s disease. The primary medical conditions associated with LEQEMBI treatment include:
- Mild Cognitive Impairment (MCI) Due to Alzheimer’s Disease: This condition represents an early stage of Alzheimer’s where individuals experience noticeable but generally mild changes in memory and thinking skills. It’s more than the normal forgetfulness associated with aging but not as severe as Alzheimer’s disease.
- Mild Dementia Due to Alzheimer’s Disease: In this stage, memory loss and cognitive impairments become more pronounced and start to interfere with daily activities and independence. Symptoms might include difficulty with memory, language, problem-solving, and other cognitive abilities that affect a person’s ability to perform everyday activities.
LEQEMBI works by targeting and reducing amyloid beta plaques in the brain, which are a hallmark of Alzheimer’s disease, potentially slowing the progression of the condition in patients with these early stages of Alzheimer’s disease with confirmed presence of amyloid pathology.
Innovative Healthcare Approach
LEQEMBI represents an innovative approach to Alzheimer’s treatment, employing the latest in biomedical research to target the disease’s pathology directly, offering new hope to patients and their families.
Patient Alzeimer’s Management Comparisons
Clinical studies have demonstrated LEQEMBI’s effectiveness in managing Alzheimer’s symptoms, showing a marked improvement in cognitive functions compared to traditional treatments.
Physician Benefits
Physicians can now offer LEQEMBI as a cutting-edge treatment option, enhancing patient care and providing a new avenue for managing Alzheimer’s disease.
Expert Problem Wound Management
We employ the Wagner Classification System for managing complex wounds, ensuring a precise and effective treatment plan for a range of wound types and severities.
Benefits of LEQEMBI
- Slows Disease Progression: LEQEMBI targets the underlying causes of Alzheimer’s, potentially slowing the disease’s progression.
- Improves Cognitive Functions: Designed to improve cognitive functions, enhancing daily living for those with Alzheimer’s disease.
- Supported by Clinical Research: Backed by extensive research and clinical trials, LEQEMBI is at the forefront of Alzheimer’s care.
Potential Side Effects
While LEQEMBI is a significant step forward, it’s important to be aware of potential side effects, such as ARIA (Amyloid Related Imaging Abnormalities), which may include headache, confusion, dizziness, vision changes, nausea, and difficulty walking.
Contact Us
For more information about LEQEMBI and how it can make a difference in Alzheimer’s care, please contact us. Our team is ready to provide support and answer any questions you may have.
Helpful Resources
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read
